lilly tirzepatide trial says weight loss drug cuts heart failure risk by 38% in COMMIT-CD: A Phase 3b trial

The 1888 paper sat largely unnoticed for the next three decades but the date of first observation remains 1888, and the molecule has been continuously studied ever since

234, 800 Stitt, A

Patents for newer GLP-1 medications like Ozempic and Wegovy wont expire until several years down the road

What are the studys key findings

Its been studied extensively for conditions ranging from respiratory health to metabolic and mental well-being

Without the appetite-regulating effects of a GLP-1 in place, that shift can quietly contribute to weight gainnot because of one choice, but because hunger keeps resurfacing throughout the day